Statins cut pneumonia risk in diabetic patients

Statin treatment could halve the risk of pneumonia in patients with diabetes, Dutch researchers have claimed.

Analysis of data from the UK General Practice Research Database indicated that statins might prevent respiratory infections.

The study included 4,719 patients with type-one or type-two diabetes who had a first recorded diagnosis of pneumonia and 15,322 diabetic controls matched for age, sex and practice.

Overall, 1.1 per cent of cases and 2.1 per cent of controls were taking statins at the index date.

The researchers found a 51 per cent reduced chance of developing pneumonia among statin users. The findings add to growing evidence that statins have immune and inflammatory effects, in addition to lipid-lowering properties.

The researchers suggested that statins could have a similar effect in the general population.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus